NO301074B1 - Analogifremgangsmåte for fremstilling av terapeutisk aktive analoger av peptidasesubstrater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive analoger av peptidasesubstrater Download PDF

Info

Publication number
NO301074B1
NO301074B1 NO894300A NO894300A NO301074B1 NO 301074 B1 NO301074 B1 NO 301074B1 NO 894300 A NO894300 A NO 894300A NO 894300 A NO894300 A NO 894300A NO 301074 B1 NO301074 B1 NO 301074B1
Authority
NO
Norway
Prior art keywords
formula
alcohol
equivalents
reaction
reacting
Prior art date
Application number
NO894300A
Other languages
English (en)
Norwegian (no)
Other versions
NO894300D0 (no
NO894300L (no
Inventor
Daniel Schirlin
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO894300D0 publication Critical patent/NO894300D0/no
Publication of NO894300L publication Critical patent/NO894300L/no
Publication of NO301074B1 publication Critical patent/NO301074B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Luminescent Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
  • Radio Relay Systems (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pyrrole Compounds (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO894300A 1988-10-28 1989-10-27 Analogifremgangsmåte for fremstilling av terapeutisk aktive analoger av peptidasesubstrater NO301074B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88402735A EP0371179A1 (en) 1988-10-28 1988-10-28 Novel analogs of peptidase substrates

Publications (3)

Publication Number Publication Date
NO894300D0 NO894300D0 (no) 1989-10-27
NO894300L NO894300L (no) 1990-04-30
NO301074B1 true NO301074B1 (no) 1997-09-08

Family

ID=8200435

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894300A NO301074B1 (no) 1988-10-28 1989-10-27 Analogifremgangsmåte for fremstilling av terapeutisk aktive analoger av peptidasesubstrater

Country Status (18)

Country Link
US (1) US5114927A (da)
EP (2) EP0371179A1 (da)
JP (1) JP2899327B2 (da)
CN (1) CN1031880C (da)
AT (1) ATE147405T1 (da)
AU (1) AU622723B2 (da)
CA (1) CA2001265C (da)
DE (1) DE68927630T2 (da)
DK (1) DK537589A (da)
ES (1) ES2099072T3 (da)
FI (1) FI95272C (da)
GR (1) GR3023027T3 (da)
HU (1) HU209311B (da)
IL (1) IL92102A (da)
NO (1) NO301074B1 (da)
PH (1) PH27239A (da)
PT (1) PT92140B (da)
ZA (1) ZA898026B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0356595A1 (en) * 1988-09-01 1990-03-07 Merrell Dow Pharmaceuticals Inc. Novel peptidase inhibitors
ZA905737B (en) * 1989-07-26 1991-05-29 Merrell Dow Pharma Novel peptidase inhibitors
IL95380A0 (en) * 1989-09-05 1991-06-30 Abbott Lab Peptidyl difluorodiol renin inhibitors
US5714470A (en) 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
DE69522940T2 (de) * 1994-06-02 2002-04-04 Merrell Pharmaceuticals Inc., Cincinnati Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren
EP0763055B1 (en) * 1994-06-02 1999-11-03 Merrell Pharmaceuticals Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
AP1019A (en) 1996-10-18 2001-10-16 Vertex Pharma Inhibitors of serinre proteases, particularly hepatitis C virus NS3 protease.
UY28500A1 (es) 2003-09-05 2005-04-29 Vertex Pharma Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc.
FR2914920B1 (fr) * 2007-04-11 2011-09-09 Clariant Specialty Fine Chem F Procede de deacetalisation d'alpha-aminoacetals.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
WO1986006379A1 (en) * 1985-04-19 1986-11-06 The Upjohn Company Dihalo-statine substituted renin inhibitors
DE3683541D1 (de) * 1985-06-07 1992-03-05 Ici America Inc Selektionierte difluorverbindungen.
EP0258289A4 (en) * 1986-01-16 1991-01-02 Joseph Dellaria Peptide analogs
GB8711748D0 (en) * 1986-06-05 1987-06-24 Ici America Inc Difluoro keto compounds
NZ223148A (en) * 1987-01-16 1989-10-27 Merrell Dow Pharma Peptide derivatives having peptidase inhibition activity

Also Published As

Publication number Publication date
DE68927630D1 (de) 1997-02-20
NO894300D0 (no) 1989-10-27
ES2099072T3 (es) 1997-05-16
JPH02172961A (ja) 1990-07-04
ATE147405T1 (de) 1997-01-15
EP0371179A1 (en) 1990-06-06
CA2001265C (en) 2001-05-01
ZA898026B (en) 1990-07-25
PT92140A (pt) 1990-04-30
GR3023027T3 (en) 1997-07-30
NO894300L (no) 1990-04-30
IL92102A0 (en) 1990-07-12
JP2899327B2 (ja) 1999-06-02
PH27239A (en) 1993-05-04
IL92102A (en) 1994-07-31
PT92140B (pt) 1996-03-29
AU622723B2 (en) 1992-04-16
FI95272B (fi) 1995-09-29
HU895473D0 (en) 1990-01-28
DK537589A (da) 1990-04-29
CN1031880C (zh) 1996-05-29
CA2001265A1 (en) 1990-04-28
FI95272C (fi) 1996-01-10
DE68927630T2 (de) 1997-06-12
US5114927A (en) 1992-05-19
HU209311B (en) 1994-04-28
AU4386789A (en) 1990-05-03
HUT51649A (en) 1990-05-28
CN1043504A (zh) 1990-07-04
EP0368719A3 (en) 1991-10-02
EP0368719B1 (en) 1997-01-08
DK537589D0 (da) 1989-10-27
FI895109A0 (fi) 1989-10-27
EP0368719A2 (en) 1990-05-16

Similar Documents

Publication Publication Date Title
US5498728A (en) Derivatives of L-tryptophanal and their use as medicinals
EP1638968B1 (en) Hexahydropyridoisoqinolines as dpp-iv inhibitors
AU663207B2 (en) Inhibitors of retroviral proteases
DE69427557T2 (de) Peptide-Analoge mit irreversibler Interleukin-1 Beta-Protease Inhibitoren
AU665536B2 (en) Novel sphingoglycolipid and use thereof
HUP0300908A2 (hu) 3-Nitrogén-6,7-dioxigén-szteroidok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
US4954512A (en) Anti-ulcer composition
HUP0200644A2 (hu) Szacharidcsoporttal helyettesített 1,4-benzotiazepin-1,1-dioxid-származékok, eljárás a vegyületek előállítására, ilyen vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
JPS62230757A (ja) ヒドロキシルアミン誘導体
HU208703B (en) Process for producing orally administrable elastase inhibitors and pharamceutical compositions containing them
EA027363B1 (ru) Производные бетулина
NO301074B1 (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive analoger av peptidasesubstrater
EP1049703A1 (en) N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme
CZ137994A3 (en) Peptide phosphonyloxymethyl ketone, pharmaceutical composition containing thereof and the use of such ketone or the pharmaceutical composition
EP3440051B1 (en) Neuropeptide s receptor (npsr) agonists
EP1262181B1 (en) Use of isothiazole derivatives as urease inhibitors for the treatment of helicobacter pylori induced gastrointestinal diseases
Ghosh et al. Potent HIV-1 protease inhibitors: stereoselective synthesis of a dipeptide mimic
FR2614533A1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments
HRP20030385A2 (en) Lactam compound
US5441932A (en) Sugar compounds for inhibition of the biosynthesis of sugar chains containing sialic acid
HU198740B (en) Process for producing aminoglycoside steroids and pharmaceutical compositions comprising these compounds as active ingredients
US4748187A (en) Opioid peptide-degrading enzyme inhibitor with a germanium compound
EP1657244B1 (en) 2-thiaquinolizidines as glycosidase and glycosyltransferase inhibitors
EP1385858A1 (fr) Nouveaux derives 5-thio-ss-d-xylopyranosides, procede de preparation, compositions pharmaceutiques les contenant et leur utilisation en therapeutique
EP0309261B1 (en) Butenoic acid amides, their salts, pharmaceutical compositions containing them and process for preparing same

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees